放射性皮膚炎市場（按產品類型、分銷管道和地區）

Radiodermatitis Market, By Product Type, By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: 2025年05月19日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

放射性皮膚炎市場規模預計在 2025 年為 4.428 億美元，預計到 2032 年將達到 5.946 億美元，2025 年至 2032 年的複合年成長率為 4.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	4.428億美元
效能數據	2020-2024	預測期	2025-2032
預測期間：2025年至2032年的複合年成長率	4.30%	2032年價值預測	5.946億美元

放射性皮膚炎 (放射性皮膚炎、放射相關皮膚反應、放射損傷) 是癌症治療或核襲擊和災難（如 2011 年福島）期間電離輻射的嚴重副作用。具體而言，95% 接受放射線治療的癌症患者會出現某種形式的放射性皮膚炎，包括紅斑。放射性皮膚炎可以包括紅斑、乾性脫屑和濕性脫屑。此類放射引起的皮膚反應會導致無數併發症，包括延遲治療、美觀度差和生活品質下降。最近的技術進步和新治療方法僅部分成功地減輕了這些有害的副作用。放射性皮膚炎最常見的原因是放射線治療，用於治療癌症和其他疾病。災難和核子襲擊也會導致這種情況。分銷管道包括零售和線上藥局。

市場動態

放射性皮膚炎，又稱X光皮疹、放射性皮膚炎、放射性皮膚反應和放射性損傷，是外部電離輻射的副作用。放射性皮膚炎的主要原因是用於治療癌症和其他疾病的放射線治療。核襲擊和災難也可能導致放射性皮膚炎。例如，美國生物技術資訊中心（NCBI）於2020年5月14日發表的一篇論文解釋說，向患者推薦的產品均未基於循證實踐，這些產品在預防或治療放射性皮膚炎方面的有效性不可信。先前，有研究建議使用尿素霜進行濕潤護膚，以有效減輕急性皮膚反應的嚴重程度。最近的報告還建議使用類固醇、金盞花、貫葉連翹和印楝油來治療急性放射性皮膚炎。

研究的主要特點

本報告對全球放射性皮膚炎市場進行了詳細分析，並以 2024 年為基準年，預測了 2025 年至 2032 年期間的市場規模和年複合成長率(CAGR)。
它還揭示了不同領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，介紹了全球放射性皮膚炎市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球放射性皮膚炎市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過全球放射性皮膚炎市場分析中使用的各種策略矩陣更輕鬆地做出決策。

介紹
北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 東南亞國協
- 澳洲
- 韓國
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 北非
- 中部非洲
- 南非

第7章競爭態勢

Acelity, Inc.（3M）
BMG Pharma Srl
ConvaTec Group PLC
DermaSciences Inc.（Integra LifeSciences Holdings Corporation）
Intermed Pharmaceuticals
Molnlycke Health Care
Smith & Nephew Plc
Stratpharma AG
Kannalife, Inc.
McKesson Corporation

第 8 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI3881

Radiodermatitis Market is estimated to be valued at USD 442.8 Mn in 2025 and is expected to reach USD 594.6 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 442.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.30%	2032 Value Projection:	USD 594.6 Mn

Radiodermatitis (radiation dermatitis, radiation-related skin reactions, or radiation damage) is a serious side effect of ionizing radiation during cancer therapy and nuclear attacks and disasters such as Fukushima in 2011. Specifically, 95% of cancer patients receiving radiation therapy develop some form of radiation dermatitis, including erythema. , dry scale and moist scale. These skin reactions to radiation lead to countless complications, such as treatment delays, reduced aesthetic appeal, and reduced quality of life. Recent technological advances and new treatment regimens have only partially succeeded in alleviating these harmful side effects. The most common cause of radiation dermatitis is radiation therapy, which is used to treat cancer and other disorders. Disasters and nuclear assaults may also contribute to the condition. Retail pharmacies and online pharmacies are included in the distribution route.

Market Dynamics

Radiation dermatitis, also known as X-ray rash, radiation dermatitis, radiation skin reactions or radiation damage, is a side effect of external ionizing radiation. Radiation therapy, used to treat cancer or other diseases, is a leading cause of radiation dermatitis. Nuclear attacks and disasters can also cause the condition. For instance, on May 14, 2020, an article published by National Center for Biotechnology Information (NCBI) explained none of the recommended products for patients are based on evidence-based practice, and the effectiveness of these products in preventing or treating radiation dermatitis is not reliable. It has previously been suggested that moist skin care with urea cream is effective in reducing the severity of acute skin reactions. In addition, recent reports have recommended the use of steroids, calendula, Hypericum perforatum, and neem oil for the treatment of acute radiodermatitis.

Key features of the study

This report provides an in-depth analysis of the global radiodermatitis market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global radiodermatitis market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Acelity, Inc. (3M), BMG Pharma S.r.l., ConvaTec Group PLC, DermaSciences Inc. (Integra LifeSciences Holdings Corporation), Intermed Pharmaceuticals, Molnlycke Health Care, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc., McKesson Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global radiodermatitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiodermatitis market.

Market Segmentation

Global Radiodermatitis Market, By Product Type
- Topical Agents
- Corticosteroids
- Hydrophilic Creams
- Others
- Oral Medication
- Corticosteroids
- Other
- Analgesic & Anti-Inflammatory
- Dressing
- Hydrogel, Hydrocolloid
- No Sting Barrier Film
- Honey Impregnated Dressing
- Silicone coated Dressing
- Others
Global Radiodermatitis Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Radiodermatitis Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Acelity, Inc. (3M)
- BMG Pharma S.r.l.
- ConvaTec Group PLC
- DermaSciences Inc. (Integra LifeSciences Holdings Corporation)
- Intermed Pharmaceuticals
- Molnlycke Health Care
- Smith & Nephew Plc.
- Stratpharma AG
- Kannalife, Inc.
- McKesson Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Radiodermatitis Market, By Product Type, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Topical Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  - Corticosteroids
  - Hydrophilic Creams
  - Others
Oral Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  - Corticosteroids
  - Other
Analgesic & Anti-Inflammatory
Dressings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  - Hydrogel
  - Hydrocolloid
  - No Sting Barrier Film
  - Honey Impregnated Dressing
  - Silicone coated Dressing
  - Others

5. Global Radiodermatitis Market, By Distribution Channel, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Radiodermatitis Market, By Region, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa